VOL. 127 | NO. 35 | Tuesday, February 21, 2012
Accredo Health Sees 2011 Record Growth
By Aisling Maki
Memphis-based Accredo Health Group, a provider of specialty pharmaceuticals, continued its record growth in fourth quarter 2011, with revenue growth of 28.3 percent to $3.8 billion. Accredo’s full-year 2011 revenues increased 18.5 percent to a record $13.4 billion.
Increases in manufacturer brand pricing, broader use of specialty products and the impact of recently introduced drugs contributed to that growth, according to the company. Product categories that experienced the highest levels of revenue growth include those related to multiple sclerosis, rheumatoid arthritis, oncology and hepatitis.
Accredo employs 5,000 individuals at more than 80 locations, with the largest pool – about 1,800 – based in Memphis.
Accredo’s parent company is New Jersey-based Medco Health Solutions Inc., which on Tuesday reported Q4 net revenues of nearly $19 billion, representing a 12.2 percent increase over Q4 2010. Medco’s full-year 2011 net revenues increased 6.2 percent over 2010 to a record $70.1 billion.